FNNZ.F Stock Overview

Does not have significant operations. More details

FNNZ.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Earnings have grown 30.3% per year over the past 5 years

Risk Analysis

Negative shareholders equity

Makes less than USD$1m in revenue (CA$-487K)

Does not have a meaningful market cap ($5M)

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

FinCanna Capital Corp. Competitors

SenesTech

NasdaqCM:SNES

US$3.4m

InMed Pharmaceuticals

NasdaqCM:INM

US$3.8m

NovaBay Pharmaceuticals

NYSEAM:NBY

US$3.3m

Sonoma Pharmaceuticals

NasdaqCM:SNOA

US$4.0m

Price History & Performance

Summary of share price highs, lows and changes for FinCanna Capital
Historical stock prices
Current Share Price	CA$0.0019
52 Week High	CA$0.008
52 Week Low	CA$0.0002
Beta	1.52
1 Month Change	164.29%
3 Month Change	-22.92%
1 Year Change	-15.91%
3 Year Change	-98.68%
5 Year Change	-99.74%
Change since IPO	-99.98%

Recent updates

Shareholder Returns

	FNNZ.F	US Pharmaceuticals	US Market
7D	0%	-1.4%	1.2%
1Y	-15.9%	-1.8%	23.7%

Return vs Industry: FNNZ.F underperformed the US Pharmaceuticals industry which returned -1.8% over the past year.

Return vs Market: FNNZ.F underperformed the US Market which returned 23.7% over the past year.

Price Volatility

Is FNNZ.F's price volatile compared to industry and market?
FNNZ.F volatility
FNNZ.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.8%
Market Average Movement	5.9%
10% most volatile stocks in US Market	18.0%
10% least volatile stocks in US Market	3.0%

Stable Share Price: FNNZ.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine FNNZ.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Vern Vipul	n/a

FinCanna Capital Corp. does not have significant operations. Previously, the company provided financing for companies operating in the cannabis sector. FinCanna Capital Corp. is headquartered in Vancouver, Canada.

FinCanna Capital Corp. Fundamentals Summary

How do FinCanna Capital's earnings and revenue compare to its market cap?
FNNZ.F fundamental statistics
Market cap	US$3.50m
Earnings (TTM)	-US$238.00k
Revenue (TTM)	n/a

-10.2x

P/S Ratio

-14.7x

P/E Ratio

Is FNNZ.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FNNZ.F income statement (TTM)
Revenue	-CA$486.94k
Cost of Revenue	CA$0
Gross Profit	-CA$486.94k
Other Expenses	-CA$148.35k
Earnings	-CA$338.59k

Last Reported Earnings

Oct 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.00034
Gross Margin	100.00%
Net Profit Margin	69.53%
Debt/Equity Ratio	-89.4%

How did FNNZ.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/20 11:46
End of Day Share Price	2025/02/07 00:00
Earnings	2024/10/31
Annual Earnings	2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

FinCanna Capital Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Siddharth Rajeev	Fundamental Research Corp.